Cargando…

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are severely debilitating and progressive neurodegenerative disorders. A distinctive pathological feature of several neurodegenerative diseases, including ALS and FTD, is the deposition of aberrant protein inclusions in neuronal c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vignaroli, Francesca, Mele, Angelica, Tondo, Giacomo, De Giorgis, Veronica, Manfredi, Marcello, Comi, Cristoforo, Mazzini, Letizia, De Marchi, Fabiola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844364/ https://www.ncbi.nlm.nih.gov/pubmed/36648959 http://dx.doi.org/10.3390/proteomes11010001

Ejemplares similares

Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
por: De Marchi, Fabiola, et al.
Publicado: (2021)

The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
por: Virgilio, Eleonora, et al.
Publicado: (2022)

Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers
por: Tondo, Giacomo, et al.
Publicado: (2022)

Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit
por: Grossini, Elena, et al.
Publicado: (2023)

Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review
por: Lombardi, Michele, et al.
Publicado: (2023)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
por: Tondo, Giacomo, et al.
Publicado: (2023)

TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration
por: Tondo, Giacomo, et al.
Publicado: (2019)

Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series
por: Magistrelli, Luca, et al.
Publicado: (2021)

Editorial: What's next? Innovative translational markers across the ALS-FTD continuum
por: De Marchi, Fabiola, et al.
Publicado: (2023)

From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?
por: Tondo, Giacomo, et al.
Publicado: (2022)

Increased Prevalence of Neuropsychiatric Disorders during COVID-19 Pandemic in People Needing a Non-Deferrable Neurological Evaluation
por: Tondo, Giacomo, et al.
Publicado: (2021)

COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature
por: Virgilio, Eleonora, et al.
Publicado: (2022)

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

A novel GRN mutation in an Italian patient with non-fluent variant of primary progressive aphasia at onset: a longitudinal case report
por: Castelnovo, Veronica, et al.
Publicado: (2023)

Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
por: De Marchi, Fabiola, et al.
Publicado: (2020)

The impact of COVID-19 pandemic on cognition of people with dementia
por: Tondo, Giacomo, et al.
Publicado: (2021)

The Impact of the COVID-19 Pandemic on the Cognition of People with Dementia
por: Tondo, Giacomo, et al.
Publicado: (2021)

Safety of COVID-19 Vaccines: Spotlight on Neurological Complications
por: Tondo, Giacomo, et al.
Publicado: (2022)

The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations
por: Grossini, Elena, et al.
Publicado: (2022)

Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum
por: Steketee, Rebecca M.E., et al.
Publicado: (2016)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
por: Hedl, Thomas J., et al.
Publicado: (2019)

Plasma proteome profiling identifies changes associated to AD but not to FTD
por: Mofrad, R. Babapour, et al.
Publicado: (2022)

Occipital Neuralgia in Chiari I Malformation: Two Different Events or Two Different Faces of the Same Event?
por: Tondo, Giacomo, et al.
Publicado: (2017)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

Examining the language and behavioural profile in FTD and ALS-FTD
por: Saxon, Jennifer A, et al.
Publicado: (2017)

Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
por: Godoy-Corchuelo, Juan Miguel, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis progression in the year of the COVID-19 pandemic
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Accelerated Early Progression of Amyotrophic Lateral Sclerosis over the COVID-19 Pandemic
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
por: Magistrelli, Luca, et al.
Publicado: (2022)

Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Variably protease‐sensitive prionopathy presenting within ALS/FTD spectrum
por: Vicente‐Pascual, Mikel, et al.
Publicado: (2018)

The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells
por: Capoferri, Davide, et al.
Publicado: (2023)

Inflammation in ALS/FTD pathogenesis
por: McCauley, Madelyn E., et al.
Publicado: (2018)

Views of LHC Point 5, site of CMS, in Cessy, France
por: Manfredi, Martin
Publicado: (2021)

Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC
por: Butera, Giovanna, et al.
Publicado: (2022)

Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
por: Béland, Louis-Charles, et al.
Publicado: (2020)

Exploring experiences and needs of spousal carers of people with behavioural variant frontotemporal dementia (bvFTD) including those with familial FTD (fFTD): a qualitative study
por: Tookey, Sara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_geniqglgmm40jt1psv67jsevqn